Michael Yi - Co-Chief Investment Officer @ Hillhouse Investment

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Primary Job Title Co-Chief Investment Officer
Primary Organization
Hillhouse Investment

Location Beijing, Beijing, China
Regions Asia-Pacific (APAC)
Gender Male
Also Known As Qingqing Yi, Yi Qingqing

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Michael Yi is based out of Beijing, Beijing and is the Co-Chief Investment Officer of Hillhouse Investment. Michael attended the Marshall School of Business at the University.

Personal Investments

Number of Investments

Michael Yi

invested in

Xingxing Charging

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Xingxing Charging	—	Series B - Xingxing Charging	obfuscated obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Scivita Medical Technology	GL Ventures LLC	—	Series B - Scivita Medical Technology	obfuscated obfuscation
obfuscated obfuscation	Pulse	Hillhouse Investment	Yes	Series C - Pulse	obfuscated obfuscation
obfuscated obfuscation	Scivita Medical Technology	GL Ventures LLC	Yes	Series A - Scivita Medical Technology	obfuscated obfuscation
obfuscated obfuscation	Cryofocus Biotech	Hillhouse Investment	Yes	Series B - Cryofocus Biotech	obfuscated obfuscation
obfuscated obfuscation	Yingsheng Biology	Hillhouse Investment	Yes	Series B - Yingsheng Biology	obfuscated obfuscation
obfuscated obfuscation	HEMO BIOENGINEERING	Hillhouse Ventures	Yes	Series B - HEMO BIOENGINEERING	obfuscated obfuscation
obfuscated obfuscation	InventisBio	GL Ventures LLC	Yes	Series D - InventisBio	obfuscated obfuscation
obfuscated obfuscation	I-Mab Biopharma	Hillhouse Investment	Yes	Post-IPO Equity - I-Mab Biopharma	obfuscated obfuscation
obfuscated obfuscation	IASO Biotherapeutics	Hillhouse Investment	Yes	Series B - IASO Biotherapeutics	obfuscated obfuscation
obfuscated obfuscation	HiberCell	Hillhouse Investment	—	Series A - HiberCell	obfuscated obfuscation

Jobs

Number of Current Jobs

Michael Yi

is the

Co-Chief Investment Officer

Hillhouse Investment

Hillhouse Investment Co-Chief Investment OfficerJun 2005

Board and Advisor Roles

Number of Current Board & Advisor Roles

Michael Yi

is the

Board Member

NextCure

NextCure Board MemberNov 2018

Related Hubs

Hub Name	CB Rank (Hub)
Post IPO Investors with Investments in Beijing	10,559
Private Equity Firms with Investments in Beijing, Beijing	5,840
Seed Stage Investors (Top 10K)	733
Financial services startups with 1-5 investors and Angel or Series A	28,259
Asia-Pacific (APAC) Investors with Funds Raised in 2023	50,135
Investors Active in China (Top 10K)	13,671
Asia-Pacific (APAC) Early Stage Venture Investors	766
Y Combinator U.S. Portfolio Companies: Black, Latine and Female founded	66,483
Angel Investors with Investments in Asia-Pacific (APAC)	31,951
US companies acquired by companies in Asia	8,097